Tasigna popular drug used as a treatment for chronic myeloid leukemia has been proven to pose life-threatening dangers to patients. Especially, Tasigna causes acute and rapid-onset atherosclerosis that subsequently inducing peripheral vascular disease.
On straightforward terms, Tasigna contributes to a swelling of the arteries that may result in limb amputation, cardiovascular problems, and death.
Intended to give the remedy for chronic leukemia, Tasigna actually introduces a brand new and significant threat. Patients and physicians in America haven’t been cautioned for Tasigna atherosclerosis, which means tens of thousands of individuals are subjected to a serious and life-threatening threat for no fault of their own.
The maker, Novartis, was aware of this danger of acute Tasigna unwanted effects for many years; rather than warning customers, the business aggressively marketed its product as superior to other remedies. To know about Tasigna lawsuit you can refer to Tasigna Atherosclerosis Attorneys Handling National Tasigna Lawsuits.
In 2015, Novartis became embroiled in Tasigna litigation over illegal misbranding and advertising by financial kickbacks; the firm paid a settlement of $390 million into the U.S. Department of Justice.
Tasigna attorneys representing instances nationally believe that men and also the families of persons affected by Tasigna might be qualified for significant settlement through submitting Tasigna atherosclerosis lawsuits against Novartis.